Lb Pharmaceuticals (LBRX) Other Gross PP&E Adjustments (2024 - 2026)
Lb Pharmaceuticals' quarterly Other Gross PP&E Adjustments came in at -$938000.0 in Q1 2026, down 87.6% quarter-over-quarter from -$500000.0 in Q4 2025.
Lb Pharmaceuticals has reported Other Gross PP&E Adjustments for 3 years, with the latest figure at -$938000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments changed N/A year-over-year to -$938000.0; the trailing twelve-month figure through Mar 2026 stood at -$938000.0 (changed N/A YoY), and the FY2025 full-year result was -$500000.0, up 59.68% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$938000.0, down from -$500000.0 in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was -$500000.0 in Q4 2025, with the low at -$1.2 million in Q4 2024.
- Average Other Gross PP&E Adjustments over 3 years is -$909500.0, with a median of -$949000.0 recorded in 2025.
- Peak annual rise in Other Gross PP&E Adjustments reached 59.68% in 2025, while the deepest fall reached 59.68% in 2025.
- Tracing LBRX's Other Gross PP&E Adjustments over 3 years: stood at -$1.2 million in 2024, then jumped by 59.68% to -$500000.0 in 2025, then sank by 87.6% to -$938000.0 in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$938000.0 (Q1 2026), -$500000.0 (Q4 2025), and -$960000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Lb Pharmaceuticals | 789.92 Mn | 789.92 Mn | - | -938,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -938,000.00 |
| Mar 31, 2026 | -938,000.00 |
| Dec 31, 2025 | -500,000.00 |
| Dec 31, 2025 | -500,000.00 |
| Sep 30, 2025 | -960,000.00 |
| Sep 30, 2025 | -960,000.00 |
| Dec 31, 2024 | -1.24 Mn |
| Dec 31, 2024 | -1.24 Mn |